GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanexa AB (OSTO:NANEXA) » Definitions » Additional Paid-In Capital

Nanexa AB (OSTO:NANEXA) Additional Paid-In Capital : kr317.96 Mil(As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Nanexa AB Additional Paid-In Capital?


Nanexa AB's quarterly additional paid-in capital stayed the same from Dec. 2023 (kr317.96 Mil) to Mar. 2024 (kr317.96 Mil) and stayed the same from Mar. 2024 (kr317.96 Mil) to Jun. 2024 (kr317.96 Mil).

Nanexa AB's annual additional paid-in capital increased from Dec. 2021 (kr249.46 Mil) to Dec. 2022 (kr264.54 Mil) and increased from Dec. 2022 (kr264.54 Mil) to Dec. 2023 (kr317.96 Mil).

Nanexa AB Additional Paid-In Capital Historical Data

The historical data trend for Nanexa AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanexa AB Additional Paid-In Capital Chart

Nanexa AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.91 109.33 249.46 264.54 317.96

Nanexa AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 264.48 264.82 317.96 317.96 317.96

Nanexa AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Nanexa AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Nanexa AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanexa AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanexa AB (OSTO:NANEXA) » Definitions » Additional Paid-In Capital
Comparable Companies
OSTO:NEWBRY OSTO:KLAR XSAT:DICOT OSTO:RLS XSAT:ODI OSTO:EMPLI XSAT:PMED OSTO:GABA XSAT:ACUC OSTO:VIVE ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Virdings Alle 32B, Uppsala, SWE, 75450
Website
https://www.nanexa.com
Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its own products and also has collaboration agreements with several pharma companies, among others AstraZeneca.

Nanexa AB Headlines

No Headlines